{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T16:46:08Z","timestamp":1784825168950,"version":"3.55.0"},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Nagourney Institute","award":["ID# 95-4731388, Grant 001-2021"],"award-info":[{"award-number":["ID# 95-4731388, Grant 001-2021"]}]},{"name":"National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health","award":["UL1 TR001414"],"award-info":[{"award-number":["UL1 TR001414"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>This study investigated the association between COVID-19 infection and host metabolic signatures as prognostic markers for disease severity and mortality. We enrolled 82 patients with RT-PCR confirmed COVID-19 infection who were classified as mild, moderate, or severe\/critical based upon their WHO clinical severity score and compared their results with 31 healthy volunteers. Data on demographics, comorbidities and clinical\/laboratory characteristics were obtained from medical records. Peripheral blood samples were collected at the time of clinical evaluation or admission and tested by quantitative mass spectrometry to characterize metabolic profiles using selected metabolites. The findings in COVID-19 (+) patients reveal changes in the concentrations of glutamate, valeryl-carnitine, and the ratios of Kynurenine\/Tryptophan (Kyn\/Trp) to Citrulline\/Ornithine (Cit\/Orn). The observed changes may serve as predictors of disease severity with a (Kyn\/Trp)\/(Cit\/Orn) Receiver Operator Curve (ROC) AUC = 0.95. Additional metabolite measures further characterized those likely to develop severe complications of their disease, suggesting that underlying immune signatures (Kyn\/Trp), glutaminolysis (Glutamate), urea cycle abnormalities (Cit\/Orn) and alterations in organic acid metabolism (C5) can be applied to identify individuals at the highest risk of morbidity and mortality from COVID-19 infection. We conclude that host metabolic factors, measured by plasma based biochemical signatures, could prove to be important determinants of Covid-19 severity with implications for prognosis, risk stratification and clinical management.<\/jats:p>","DOI":"10.1371\/journal.pone.0259909","type":"journal-article","created":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T18:23:37Z","timestamp":1638383017000},"page":"e0259909","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":22,"title":["Towards risk stratification and prediction of disease severity and mortality in COVID-19: Next generation metabolomics for the measurement of host response to COVID-19 infection"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2341-5340","authenticated-orcid":true,"given":"Paulo","family":"D\u2019Amora","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismael Dale C. G.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Auxiliadora","family":"Budib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Ayache","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafaela Moraes Siufi","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabricio Colacino","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robson Mateus","family":"Appel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saturnino Sarat","family":"J\u00fanior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrique Budib Dorsa","family":"Pontes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Carolina","family":"Alvarenga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilli Carvalho","family":"Arima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wellington Galhano","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nakal Lauren\u00e7o F.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo Sobhie","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcia B.","family":"Salzgeber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton M.","family":"Palma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven S.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Nagourney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,12,1]]},"reference":[{"issue":"7798","key":"pone.0259909.ref001","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"F Wu","year":"2020","journal-title":"Nature"},{"issue":"5","key":"pone.0259909.ref002","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.healun.2020.03.012","article-title":"COVID-19 illness in native and immunosuppressed states: A clinical-therapeutic staging proposal","volume":"39","author":"HK Siddiqi","year":"2020","journal-title":"J Heart Lung Transplant"},{"issue":"12","key":"pone.0259909.ref003","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/j.jiph.2020.07.014","article-title":"COVID-19 and comorbidities: Deleterious impact on infected patients","volume":"13","author":"H Ejaz","year":"2020","journal-title":"J Infect Public Health"},{"issue":"6","key":"pone.0259909.ref004","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/s41574-020-0353-9","article-title":"Endocrine and metabolic link to coronavirus infection","volume":"16","author":"SR Bornstein","year":"2020","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"pone.0259909.ref005","doi-asserted-by":"crossref","first-page":"e0173164","DOI":"10.1371\/journal.pone.0173164","article-title":"Correction: Plasma Metabolomics Biosignature According to HIV Stage of Infection, Pace of Disease Progression, Viremia Level and Immunological Response to Treatment","volume":"12","author":"B Scarpellini","year":"2017","journal-title":"PLoS One"},{"key":"pone.0259909.ref006","unstructured":"The WHO COVID-19 Clinical management: living guidance. https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-clinical-2021-1"},{"issue":"3","key":"pone.0259909.ref007","doi-asserted-by":"crossref","first-page":"2000045","DOI":"10.2807\/1560-7917.ES.2020.25.3.2000045","article-title":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR","volume":"25","author":"VM Corman","year":"2020","journal-title":"Euro Surveill"},{"issue":"7","key":"pone.0259909.ref008","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/jmv.25783","article-title":"Clinical features and treatment of COVID-19 patients in northeast Chongqing","volume":"92","author":"S Wan","year":"2020","journal-title":"J Med Virol"},{"issue":"5","key":"pone.0259909.ref009","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1590\/0100-3984.2020.0074","article-title":"COVID-19: a brief update for radiologists","volume":"53","author":"GSP Meirelles","year":"2020","journal-title":"Radiol Bras"},{"key":"pone.0259909.ref010","article-title":"Cholinergic and lipid mediators crosstalk in Covid-19 and the impact of glucocorticoid therapy","author":"MM P\u00e9rez","journal-title":"MedRxiv"},{"issue":"1","key":"pone.0259909.ref011","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s10654-017-0333-0","article-title":"Serum metabolites and risk of myocardial infarction and ischemic stroke: a targeted metabolomic approach in two German prospective cohorts","volume":"33","author":"A Floegel","year":"2018","journal-title":"Eur J Epidemiol"},{"key":"pone.0259909.ref012","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12916-016-0552-3","article-title":"Higher plasma levels of lysophosphatidylcholine 18:0 are related to a lower risk of common cancers in a prospective metabolomics study","volume":"14","author":"T K\u00fchn","year":"2016","journal-title":"BMC Med"},{"issue":"2","key":"pone.0259909.ref013","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2337\/db12-0495","article-title":"Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach","volume":"62","author":"A Floegel","year":"2013","journal-title":"Diabetes"},{"issue":"8","key":"pone.0259909.ref014","doi-asserted-by":"crossref","first-page":"e0135437","DOI":"10.1371\/journal.pone.0135437","article-title":"Reliability of Serum Metabolites over a Two-Year Period: A Targeted Metabolomic Approach in Fasting and Non-Fasting Samples from EPIC","volume":"10","author":"M Carayol","year":"2015","journal-title":"PLoS One"},{"issue":"11","key":"pone.0259909.ref015","doi-asserted-by":"crossref","first-page":"e13953","DOI":"10.1371\/journal.pone.0013953","article-title":"Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting","volume":"5","author":"K Suhre","year":"2010","journal-title":"PLoS One"},{"issue":"1","key":"pone.0259909.ref016","doi-asserted-by":"crossref","first-page":"e86","DOI":"10.1002\/cpbi.86","article-title":"Using MetaboAnalyst 4.0 for Comprehensive and Integrative Metabolomics Data Analysis","volume":"68","author":"J Chong","year":"2019","journal-title":"Curr Protoc Bioinformatics"},{"key":"pone.0259909.ref017","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.cca.2018.08.014","article-title":"Influence of collection tubes during quantitative targeted metabolomics studies in human blood samples","volume":"486","author":"G Paglia","year":"2018","journal-title":"Clin Chim Acta"},{"key":"pone.0259909.ref018","article-title":"MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights","author":"Z Pang","year":"2021","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"pone.0259909.ref019","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1001\/jama.2020.12839","article-title":"Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review","volume":"324","author":"WJ Wiersinga","year":"2020","journal-title":"JAMA"},{"issue":"4","key":"pone.0259909.ref020","doi-asserted-by":"crossref","first-page":"e0250780","DOI":"10.1371\/journal.pone.0250780","article-title":"Risk of rapid evolutionary escape from biomedical interventions targeting SARS-CoV-2 spike protein","volume":"16","author":"D Van Egeren","year":"2021","journal-title":"PLoS One"},{"issue":"1","key":"pone.0259909.ref021","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1001\/jamainternmed.2020.6047","article-title":"Severe COVID-19 Infections-Knowledge Gained and Remaining Questions","volume":"181","author":"LDJ Bos","year":"2021","journal-title":"JAMA Intern Med"},{"key":"pone.0259909.ref022","article-title":"SARS-CoV-2 Uses CD4 to Infect T Helper Lymphocytes","author":"Davanzo","year":"2020","journal-title":"MedRxiv"},{"issue":"11","key":"pone.0259909.ref023","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.3390\/jcm10112484","article-title":"Crosstalk between Tryptophan Metabolism via Kynurenine Pathway and Carbohydrate Metabolism in the Context of Cardio-Metabolic Risk-Review","volume":"10","author":"M Kiluk","year":"2021","journal-title":"J Clin Med"},{"key":"pone.0259909.ref024","doi-asserted-by":"crossref","first-page":"721556","DOI":"10.3389\/fgene.2021.721556","article-title":"Metabolomics in the Diagnosis and Prognosis of COVID-19","volume":"12","author":"MR Hasan","year":"2021","journal-title":"Front Genet"},{"issue":"2","key":"pone.0259909.ref025","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1053\/j.gastro.2020.04.064","article-title":"Clinical Characteristics and Outcomes of Coronavirus Disease 2019 Among Patients With Preexisting Liver Disease in the United States: A Multicenter Research Network Study","volume":"159","author":"S Singh","year":"2020","journal-title":"Gastroenterology"},{"issue":"5","key":"pone.0259909.ref026","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3390\/ijms20051149","article-title":"An Updated Review of Lysophosphatidylcholine Metabolism in Human Diseases","volume":"20","author":"SH Law","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"8","key":"pone.0259909.ref027","doi-asserted-by":"crossref","first-page":"e0256784","DOI":"10.1371\/journal.pone.0256784","article-title":"Immunometabolic signatures predict risk of progression to sepsis in COVID-19","volume":"16","author":"AS Herrera-Van Oostdam","year":"2021","journal-title":"PLoS One"},{"issue":"1","key":"pone.0259909.ref028","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1038\/s41598-021-82426-7","article-title":"Dysregulation of lipid metabolism and pathological inflammation in patients with COVID-19","volume":"11","author":"M Caterino","year":"2021","journal-title":"Sci Rep"},{"issue":"14","key":"pone.0259909.ref029","doi-asserted-by":"crossref","first-page":"e140327","DOI":"10.1172\/jci.insight.140327","article-title":"COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status","volume":"5","author":"T Thomas","year":"2020","journal-title":"JCI Insight"},{"key":"pone.0259909.ref030","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1750-1172-7-32","article-title":"Suggested guidelines for the diagnosis and management of urea cycle disorders","volume":"7","author":"J H\u00e4berle","year":"2012","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"pone.0259909.ref031","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1080\/21505594.2020.1788887","article-title":"Elite controllers: A heterogeneous group of HIV-infected patients","volume":"11","author":"MA Navarrete-Mu\u00f1oz","year":"2020","journal-title":"Virulence"},{"issue":"2","key":"pone.0259909.ref032","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1053\/j.gastro.2020.04.064","article-title":"Clinical Characteristics and Outcomes of Coronavirus Disease 2019 Among Patients With Preexisting Liver Disease in the United States: A Multicenter Research Network Study","volume":"159","author":"S Singh","year":"2020","journal-title":"Gastroenterology"},{"issue":"7","key":"pone.0259909.ref033","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/s42255-020-0237-2","article-title":"A metabolic handbook for the COVID-19 pandemic","volume":"2","author":"JS Ayres","year":"2020","journal-title":"Nat Metab"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0259909","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T18:24:22Z","timestamp":1638383062000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0259909"}},"subtitle":[],"editor":[{"given":"Andrea","family":"Motta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,12,1]]},"references-count":33,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,12,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0259909","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,1]]}}}